Less is More: Video-Assisted Thoracic Surgery (VATS) vs. Open Thoracotomy (OT) in the Management of Resectable Lung Cancer

Shagufta Shaheen, S. Otoukesh, B. Jabo, Manmeet Kaur, Nicole D Wheeler, S. Mirshahidi, S. Zaheer, H. Mirshahidi
{"title":"Less is More: Video-Assisted Thoracic Surgery (VATS) vs. Open Thoracotomy (OT) in the Management of Resectable Lung Cancer","authors":"Shagufta Shaheen, S. Otoukesh, B. Jabo, Manmeet Kaur, Nicole D Wheeler, S. Mirshahidi, S. Zaheer, H. Mirshahidi","doi":"10.4172/2329-6771.1000216","DOIUrl":null,"url":null,"abstract":"Lung cancer is the leading cause of cancer-related mortalities around the world [1]. Potentially curable early stage Non-Small-Cell Lung Cancer (NSCLC) can be found in one-third of this patient population [2]. Surgical resection remains the backbone of treatment in resectable lung cancers. The introduction of VATS in 1994 [3] sparked interest in minimally invasive tumor resection. VATS has also been shown to have fewer postoperative complications [4] and has been associated with decreased postoperative pain and increased quality of life compared to OT [5]. Several studies have compared these two approaches indirectly, but no randomized controlled trial has investigated the long-term effect on outcomes. We aim to investigate the long-term Disease-Free Survival (DFS) and OS of patients with lung cancer undergoing lung resection by OT or VATS for resectable stage lung cancer. Patients and Methods","PeriodicalId":16252,"journal":{"name":"Journal of Integrative Oncology","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2329-6771.1000216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Lung cancer is the leading cause of cancer-related mortalities around the world [1]. Potentially curable early stage Non-Small-Cell Lung Cancer (NSCLC) can be found in one-third of this patient population [2]. Surgical resection remains the backbone of treatment in resectable lung cancers. The introduction of VATS in 1994 [3] sparked interest in minimally invasive tumor resection. VATS has also been shown to have fewer postoperative complications [4] and has been associated with decreased postoperative pain and increased quality of life compared to OT [5]. Several studies have compared these two approaches indirectly, but no randomized controlled trial has investigated the long-term effect on outcomes. We aim to investigate the long-term Disease-Free Survival (DFS) and OS of patients with lung cancer undergoing lung resection by OT or VATS for resectable stage lung cancer. Patients and Methods
少即是多:视频辅助胸外科手术(VATS)与开胸手术(OT)在可切除肺癌治疗中的应用
肺癌是全球癌症相关死亡的主要原因[1]。可治愈的早期非小细胞肺癌(NSCLC)在该患者群体中占三分之一[2]。手术切除仍然是可切除肺癌的主要治疗方法。1994年VATS的引入[3]引发了人们对微创肿瘤切除术的兴趣。与OT相比,VATS也有更少的术后并发症[4],并可减少术后疼痛和提高生活质量[5]。一些研究间接比较了这两种方法,但没有随机对照试验调查对结果的长期影响。我们的目的是研究可切除期肺癌行OT或VATS肺切除术患者的长期无病生存期(DFS)和OS。患者及方法
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信